Is Zhengye Biotechnology Holding Ltd (ZYBT) Halal?

NASDAQ Healthcare China $40M
✗ NOT HALAL
Confidence: 90/100
Zhengye Biotechnology Holding Ltd (ZYBT) is Not Halal under AAOIFI Standard 21. The company's debt ratio of 243.2% exceeds the 30% threshold, indicating excessive interest-bearing debt relative to market capitalization. Zhengye Biotechnology Holding Ltd operates in the Healthcare sector.

Shariah Screening — 5 Standards

Based on financial data from December 2024

Standard Debt Ratio Cash Ratio Receivables Income Status
AAOIFI 243.2%
/ 30%
56.4%
/ 30%
249.0%
/ 30%
0.12%
/ 5%
✗ NOT HALAL
DJIM 243.2%
/ 33%
56.4%
/ 33%
249.0%
/ 33%
0.12%
/ 5%
✗ NOT HALAL
MSCI 17.5%
/ 33%
4.1%
/ 33%
17.9%
/ 33%
0.12%
/ 5%
✓ HALAL
S&P 243.2%
/ 33%
56.4%
/ 33%
249.0%
/ 33%
0.12%
/ 5%
✗ NOT HALAL
FTSE 17.5%
/ 33%
4.1%
/ 33%
17.9%
/ 50%
0.12%
/ 5%
✓ HALAL

Financial Highlights

EPS
$-0.06
P/B Ratio
0.9
EV/EBITDA
-65.2
EV: $144M
Revenue
$186M
Growth: -34.4%
Current Ratio
1.5

Profitability

Gross Margin 37.4%
Operating Margin -46.3%
Net Margin -12.6%
Return on Equity (ROE) -6.4%
Return on Assets (ROA) -3.4%

Cash Flow & Balance Sheet

Operating Cash Flow$41M
Free Cash Flow$13M
Total Debt$86M
Debt-to-Equity23.5
Current Ratio1.5
Total Assets$493M

Price & Trading

Last Close$0.85
50-Day MA$0.90
200-Day MA$3.68
Avg Volume26K
52-Week Range
$0.68
$14.30

About Zhengye Biotechnology Holding Ltd (ZYBT)

CEO
Mr. Songlin Song
Employees
277
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Country
China
Exchange
NASDAQ
Market Cap
$40M
Currency
USD

Zhengye Biotechnology Holding Limited engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in China. The company offers vaccines for swine, cattle, goats, sheep, poultry, and dogs. Its veterinary vaccines include monovalent vaccine, polyvalent vaccine, combined vaccine, and combined and polyvalent vaccine. The company also develops vaccines for household animals. In addition, it exports its products to Vietnam, Pakistan, and Egypt. The company serves direct-end customers, including livestock farmers and local governments, as well as domestic distributors and exporting distributors. The company was founded in 2004 and is based in Jilin, China. Zhengye Biotechnology Holding Limited operates as a subsidiary of Securingium Holding Limited.

Related Halal Stocks in Healthcare

Frequently Asked Questions

Is Zhengye Biotechnology Holding Ltd (ZYBT) halal to invest in?

Based on our screening using AAOIFI Standard 21 (the strictest methodology), Zhengye Biotechnology Holding Ltd is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.

What is Zhengye Biotechnology Holding Ltd's debt ratio?

Zhengye Biotechnology Holding Ltd's debt ratio is 243.2% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 17.5%.

What are Zhengye Biotechnology Holding Ltd's key financial metrics?

Zhengye Biotechnology Holding Ltd has a market capitalization of $40M, and revenue of $186M. The company maintains a gross margin of 37.4% and a net margin of -12.6%. Return on equity stands at -6.4%.

How often is the screening data updated?

Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.

Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.